|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2009-10-5
|
|
pubmed:abstractText |
Hip fracture surgery (HFS) carries a high risk of venous thromboembolism (VTE) in the absence of thromboprophylactic treatment. Previous reports have suggested that fondaparinux sodium (FPX) administration decreases the incidence of VTE after HFS and total hip and knee arthroplasties. However, investigations of that effect in Japanese populations remain inadequate. We evaluated the efficacy of FPX after HFS in a prospective randomized controlled trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1436-2023
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
491-6
|
|
pubmed:meshHeading |
pubmed-meshheading:19802659-Aged,
pubmed-meshheading:19802659-Aged, 80 and over,
pubmed-meshheading:19802659-Anticoagulants,
pubmed-meshheading:19802659-Female,
pubmed-meshheading:19802659-Fibrin Fibrinogen Degradation Products,
pubmed-meshheading:19802659-Fracture Fixation,
pubmed-meshheading:19802659-Hip Fractures,
pubmed-meshheading:19802659-Humans,
pubmed-meshheading:19802659-Japan,
pubmed-meshheading:19802659-Male,
pubmed-meshheading:19802659-Polysaccharides,
pubmed-meshheading:19802659-Venous Thromboembolism,
pubmed-meshheading:19802659-Venous Thrombosis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Prospective randomized controlled trial on the effect of fondaparinux sodium for prevention of venous thromboembolism after hip fracture surgery.
|
|
pubmed:affiliation |
Department of Orthopedic Surgery, Yuri-Kumiai General Hospital, Yuri-Honjo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
